This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: C&c Research Laboratories. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Innovations of Bu Young Choi in Pharmaceutical Research
Introduction
Bu Young Choi is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical research, particularly in the development of heterocyclic derivatives. His work focuses on compounds that have potential therapeutic applications in treating diseases linked to the activation of specific proteins.
Latest Patents
One of Bu Young Choi's key patents is titled "Heterocyclic derivatives and use thereof." This patent describes a heterocyclic derivative represented by a specific formula, which exhibits an inhibitory effect on the activation of the STAT3 protein. This compound is particularly valuable for the prevention or treatment of diseases associated with the activation of STAT3 protein. Bu Young Choi holds 1 patent in this area.
Career Highlights
Bu Young Choi is currently employed at C&C Research Laboratories, where he continues to advance his research in pharmaceutical innovations. His work has the potential to impact the treatment of various diseases, showcasing his commitment to improving healthcare through scientific discovery.
Collaborations
Throughout his career, Bu Young Choi has collaborated with talented individuals such as Chan Hee Park and Sang Hwi Lee. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Bu Young Choi's contributions to pharmaceutical research, particularly through his innovative patent on heterocyclic derivatives, highlight his role as a significant inventor in the field. His ongoing work at C&C Research Laboratories continues to pave the way for advancements in medical treatments.